Sodium–Glucose Cotransporter-2 Inhibitor, Empagliflozin, Suppresses the Inflammatory Immune Response to Influenza Infection
Article in ImmunoHorizons (December 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in ImmunoHorizons (December 2023)
Article in Autoimmunity Reviews (August 2023)
Article in Journal of Endocrinological Investigation (August 2023)